Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Cancer. 2021 Jul 15;127(14):2525-2534. doi: 10.1002/cncr.33506. Epub 2021 Apr 2.
Reducing disparities in men with prostate cancer (PCa) that may be caused by racial and socioeconomic differences is a major public health priority. Few reports have studied whether these disparities have changed over time.
Men diagnosed with PCa from January 1, 2000 to December 31, 2015 were identified from the Massachusetts and Pennsylvania cancer registries. All-cause mortality and PCa and cardiovascular cause-specific mortality were assessed. To estimate neighborhood socioeconomic position (nSEP), a summary score was generated using census tract-level measures of income, wealth, educational attainment, and racial and income segregation. Participants were grouped by diagnosis year (2000-2003, 2004-2007, 2008-2011, or 2012-2015), and changing trends in the mortality rate ratio by race and nSEP were estimated using covariate-adjusted Cox models with follow-up for up to 10 years, until death, or until censoring on January 1, 2018.
There were 193,883 patients with PCa and 43,661 deaths over 1,404,131 person-years of follow-up. The Black-White adjusted hazard ratio (aHR) from 2000 to 2003 through 2012 to 2015 was stable for all-cause mortality (aHR, 1.14 to 0.97; P for heterogeneity = .42), decreased for PCa-specific mortality (aHR, 1.38 to 0.93; P for heterogeneity = .005), and increased for cardiovascular mortality (aHR, 1.09 to 1.28; P for heterogeneity = .034). The aHR comparing those in the lowest versus the highest nSEP quintile increased significantly for all-cause mortality (aHR, 1.54 to 1.79; P for heterogeneity = .008), but not for PCa-specific mortality (aHR, 1.60 to 1.72; P for heterogeneity = .40) or cardiovascular mortality (aHR, 1.72 to 1.89; P for heterogeneity = .085).
Although Black-White disparities in prostate mortality declined in Massachusetts and Pennsylvania over the study period, nSEP mortality disparity trends were stagnant or increased, warranting further attention.
Few reports have examined whether racial and socioeconomic disparities in prostate cancer mortality have widened or narrowed in recent years. Using data from 2 state registries (Massachusetts and Pennsylvania) with differing intensities of government-mandated health insurance, trends in racial and neighborhood socioeconomic disparities were studied among Black and White men diagnosed from 2000 to 2015. Overall, trends in racial disparities were stagnant for all-cause mortality, shrank for prostate mortality, and widened for cardiovascular mortality. Disparities associated with neighborhood socioeconomic status either were stagnant or widened across all mortality end points. In general, disparities were more pronounced in Pennsylvania than in Massachusetts.
减少可能由种族和社会经济差异引起的前列腺癌(PCa)男性之间的差异是一个主要的公共卫生重点。很少有研究报告探讨这些差异是否随时间发生了变化。
从马萨诸塞州和宾夕法尼亚州癌症登记处确定了 2000 年 1 月 1 日至 2015 年 12 月 31 日期间诊断为 PCa 的男性。评估了全因死亡率和 PCa 及心血管疾病特异性死亡率。为了估计邻里社会经济地位(nSEP),使用人口普查区层面的收入、财富、教育程度以及种族和收入隔离的衡量标准,生成了一个综合评分。参与者根据诊断年份(2000-2003 年、2004-2007 年、2008-2011 年或 2012-2015 年)分组,并使用协变量调整的 Cox 模型估计种族和 nSEP 死亡率比值的变化趋势,随访时间最长可达 10 年,直至死亡或截至 2018 年 1 月 1 日截止。
在 1404131 人年的随访中,有 193883 名患者患有 PCa 和 43661 例死亡。2000 年至 2003 年至 2012 年至 2015 年,黑人与白人的全因死亡率调整后的危险比(aHR)保持稳定(aHR,1.14 至 0.97;P 异质性=.42),PCa 特异性死亡率降低(aHR,1.38 至 0.93;P 异质性=.005),心血管死亡率增加(aHR,1.09 至 1.28;P 异质性=.034)。与最低 nSEP 五分位组相比,最高 nSEP 五分位组的全因死亡率 aHR 显著增加(aHR,1.54 至 1.79;P 异质性=.008),但 PCa 特异性死亡率(aHR,1.60 至 1.72;P 异质性=.40)或心血管死亡率(aHR,1.72 至 1.89;P 异质性=.085)无显著差异。
尽管马萨诸塞州和宾夕法尼亚州的黑人和白人前列腺癌死亡率的种族差异在研究期间有所下降,但邻里社会经济地位的死亡率差异趋势停滞不前或有所增加,值得进一步关注。
非医学专业人士请谨慎参考译文内容,或寻求专业医学翻译人员的帮助。